Drug-induced QT-interval prolongation and proarrhythmic risk in the treatment of atrial arrhythmias.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology

Volumn 9 Suppl 4, Issue , 2007, Pages

  Shantsila, Eduard ^a   Watson, Timothy ^a   Lip, Gregory Y H ^a  

^a CITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT;

CHEMICALLY INDUCED DISORDER; HEART ATRIUM FIBRILLATION; HUMAN; LONG QT SYNDROME; PATHOPHYSIOLOGY; REVIEW; RISK FACTOR; TORSADE DES POINTES;

ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; HUMANS; LONG QT SYNDROME; RISK FACTORS; TORSADES DE POINTES;

EID: 38849195722     PISSN: 10995129     EISSN: None     Source Type: Journal    
DOI: 10.1093/europace/eum169     Document Type: Review

References (86)